During the past decade, Hématologie Clinique, CHU, Hôpital d'Enfants conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hématologie Clinique, CHU, Hôpital d'Enfants" #1 collaborator was "Amgen" with 2 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Sanofi-Synthelabo" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hématologie Clinique, CHU, Hôpital d'Enfants" are "Multiple Myeloma" (2 trials), "Diffuse Large Cell Lymphoma" (1 trials) and "Untreated CD20-positive Large B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Hématologie Clinique, CHU, Hôpital d'Enfants" in a lesser frequency.

Most popular intervention types in "Hématologie Clinique, CHU, Hôpital d'Enfants" are "Drug" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Autologous stem cell transplant" (1 trials), "Carfilzomib" (1 trials), "Gemcitabine-Oxaliplatin plus Rituximab (R-GEMOX)" (1 trials), "Pomalidomide" (1 trials) and "Rituximab + ACVBP regimen plus Pegfilgrastim" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hématologie Clinique, CHU, Hôpital d'Enfants" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hématologie Clinique, CHU, Hôpital d'Enfants". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hématologie Clinique, CHU, Hôpital d'Enfants, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hématologie Clinique, CHU, Hôpital d'Enfants, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".